Nano-X (NNOX) Imaging Slashes Costs As Cash Clock Keeps Ticking

On September 9, Nano-X Imaging (NASDAQ: NNOX ) held its second-quarter earnings call, and the message was blunt: growth is real, but so is the cash burn. Revenue climbed 37% year over year to $4.2 million for the quarter ended June 30, yet the company also booked a $40.7 million impairment charge and watched its cash pile shrink by nearly half in six months. Management's answer is to strip the business down, outsource chip manufacturing, cut headcount across two continents, and lean harder on outside distributors to get its X-ray systems into more clinics before the money runs out.

Reimbursement Dollars Start Trickling In

Revenue growth was driven largely by the consolidation of the Nanox Health IT business the company acquired on November 19, 2025. Teleradiology, still the steadiest part of the business, grew 14% year over year to $3 million on an expanded client list and the renewal of a multinational aerospace contract. The AI and software line added $1 million, helped by five new installations and pilot programs launched across the US and India during the quarter.

The most interesting number in the release may be the smallest one. The company's first Nanox Imaging Network site, in Philadelphia, has already begun scanning patients and collecting insurance payments of $200 to $700 per claim. Management believes a fully utilized site could generate $500,000 to $1 million a year, a model built around segments like workers' compensation and concierge medicine where reimbursement tends to run higher. Ten signed US distribution partnerships now supplement the direct sales team, and a new Medicare code covering algorithmic analysis of coronary artery calcium, effective April 1, opens a reimbursement path for the company's cardiac AI tool. A Cedars-Sinai pilot study found the AI matched standard-of-care assessments of aortic valve calcification more than 92% of the time.

The quarter's headline number was ugly. A $40.7 million impairment charge, triggered by a falling share price and lower revenue forecasts for the AI unit, dragged GAAP gross margin to negative 1,051%, compared with negative 107% a year earlier, and pushed the GAAP net loss to $55.5 million. The charge did not touch the company's cash, but the cash needed no help getting worse on its own. Nano-X held $31.4 million as of June 30, down from $60 million as of December 31, 2025, and CFO Guy Nathanzon said the company's resources raise substantial doubt about its ability to continue as a going concern.